8400 The Health Network
Keren Leshem serves as the Chief Executive Officer and Board Director at OCON Therapeutics since September 2019, previously holding the position of Vice President Sales & Business Development. In addition, Keren Leshem is involved with several organizations, including Aspivix and RAMBAM MedTech as a Director on their Board of Directors, and has been recognized as a Tech Pioneer 2022 by the World Economic Forum. Keren Leshem also contributes as a Mentor at 8400 - The Health Network, an Advisory Board Member for LSX Femtech Leaders, and a member of the board of admissions for FemTech Lab, while participating in the HealthTech CEO Forum organized by McKinsey & Company. Previous experience includes an Entrepreneur In Residence role at the Singapore National Eye Centre and a board membership at ViSci. Keren Leshem holds an MBA from Clark University and a BA from New England College.
This person is not in any teams
8400 The Health Network
On a mission to drive an Israeli economic growth engine in HealthTech and accelerate global cure, 8400 The Health Network is weaving a network of HealthTech ecosystem leaders, across silos and sectors, who learn together and create gap-closing projects that will propel a thriving HealthTech industry in Israel. The 8400 Fellowship runs annual cohorts of 60 senior Israeli leaders each, for an intensive 17 day program across 7 months. The program’s tailor-made curriculum is creating a continuous platform for breaking silos, peer learning and designing ecosystem growth initiatives. 8400 fellowship graduates join the 8400 Network.